Hinge Health (HNGE) Climbs 17% on Revenue Jump, Double-Digit Growth Hopes

We recently published 10 Stocks Turning Heads With Double-Digit Returns. Hinge Health Inc. (NYSE:HNGE) was one of the best performers on Wednesday.

Hinge Health extended its winning streak to a third consecutive day on Wednesday, surging 17.28 percent to close at $38.76 apiece as investors took heart from strong revenue performance last year, bolstering expectations for further double-digit growth in 2026.

In an updated report, Hinge Health Inc. (NYSE:HNGE) said that it grew its revenue last year by 50.7 percent to $587.86 million from $390.4 million in 2024, albeit net loss attributable to shareholders widened by more than 3,463 percent to $424 million from $11.9 million year-on-year.

Revenues in the fourth quarter alone jumped by 45 percent to $170.7 million from $117.2 million, while attributable net profit soared by 440 percent to $31.09 million from $5.76 million year-on-year.

“We closed out the year with an exceptional quarter and a strong selling season, driving our highest win rates to date and greatest number of eligible lives added in any year,” Hinge Health Inc. (NYSE:HNGE) CEO Daniel Perez saidl

“Our commercial momentum, combined with expanding margins and strong cash generation, gives us confidence in our ability to continue automating care delivery, sustain our position as a leader in digital musculoskeletal care, and drive attractive growth and increased margins in 2026,” he added.

Amid the strong results, Hinge Health Inc. (NYSE:HNGE) issued a double-digit revenue growth outlook for both the full-year and first quarter of 2026.

In the full-year alone, revenues are targeted to grow by 25 percent at the midpoint, to a range of $732 million to $742 million, while revenues in the first quarter are expected at $171 million to $173 million, implying a 39 percent growth at the midpoint.

While we acknowledge the potential of HNGE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.